- Home
- VNDA vs BLDE Comparison
VNDA vs BLDE Comparison
Compare VNDA & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- BLDE
- Stock Information
- Founded
- VNDA 2002
- BLDE 2014
- Country
- VNDA United States
- BLDE United States
- Employees
- VNDA N/A
- BLDE N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- BLDE Aerospace
- Sector
- VNDA Health Care
- BLDE Consumer Discretionary
- Exchange
- VNDA Nasdaq
- BLDE Nasdaq
- Market Cap
- VNDA 282.8M
- BLDE 272.5M
- IPO Year
- VNDA 2006
- BLDE N/A
- Fundamental
- Price
- VNDA $4.69
- BLDE $3.04
- Analyst Decision
- VNDA Strong Buy
- BLDE Strong Buy
- Analyst Count
- VNDA 2
- BLDE 2
- Target Price
- VNDA $16.50
- BLDE $6.25
- AVG Volume (30 Days)
- VNDA 584.2K
- BLDE 694.4K
- Earning Date
- VNDA 05-07-2025
- BLDE 03-13-2025
- Dividend Yield
- VNDA N/A
- BLDE N/A
- EPS Growth
- VNDA N/A
- BLDE N/A
- EPS
- VNDA N/A
- BLDE N/A
- Revenue
- VNDA $198,772,000.00
- BLDE $248,693,000.00
- Revenue This Year
- VNDA $14.36
- BLDE $5.29
- Revenue Next Year
- VNDA $44.53
- BLDE $8.99
- P/E Ratio
- VNDA N/A
- BLDE N/A
- Revenue Growth
- VNDA 3.18
- BLDE 10.44
- 52 Week Low
- VNDA $3.86
- BLDE $2.60
- 52 Week High
- VNDA $6.75
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- VNDA 49.19
- BLDE 41.24
- Support Level
- VNDA $4.84
- BLDE $2.94
- Resistance Level
- VNDA $5.04
- BLDE $3.21
- Average True Range (ATR)
- VNDA 0.20
- BLDE 0.20
- MACD
- VNDA -0.02
- BLDE 0.03
- Stochastic Oscillator
- VNDA 25.00
- BLDE 23.96
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.